Publications
- Ocrelizumab since the first multiple sclerosis attack - a milestone in reimbursement criteria2022 | First Faculty of Medicine
- Clinical-radiological paradox in multiple sclerosis - the role of the spinal cord examination2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?2024 | First Faculty of Medicine
- COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark2024 | First Faculty of Medicine
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Progressive multiple sclerosis in the light of the latest findings2023 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!2023 | First Faculty of Medicine
- Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences2023 | First Faculty of Medicine
- Early high efficacy mulitple sclerosis treatment: therapeutic success despite safety barriers2023 | First Faculty of Medicine
Loading network view...